Sandoz Group AG is a global leader in the pharmaceuticals industry, specializing in the development and manufacture of generic drugs and biosimilars. The company, part of the Novartis Group until its ... Sandoz Group AG is a global leader in the pharmaceuticals industry, specializing in the development and manufacture of generic drugs and biosimilars. The company, part of the Novartis Group until its spin-off, focuses on providing affordable alternatives to innovative medicines, helping to make healthcare more accessible worldwide. Sandoz's portfolio encompasses a wide array of therapeutic areas, including cardiovascular, central nervous system disorders, oncology, and respiratory diseases. The company's robust pipeline is aimed at addressing unmet medical needs through its commitment to quality, innovation, and sustainability. Sandoz plays a significant role in the global healthcare ecosystem by reducing healthcare costs and increasing the availability of essential medicines. Its strong presence in both developed and emerging markets underscores its importance in promoting global health. Sandoz's dedication to efficiency and effectiveness in pharmaceutical manufacturing has established it as a key player in the generic drug sector, substantially influencing healthcare delivery and access.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Sandoz Group is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Sandoz Group is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Sandoz Group's data?

Start your 30-day free trial to request a data review for Sandoz Group.

Start Free Trial

Legal Center Contact Us